Clear Eyes Redness Relief Club Pack Display; each display contains 18 3-Pack bottles (UPC 6 78112...
FDA Drug Recall #D-1829-2019 — Class II — July 26, 2019
Recall Summary
| Recall Number | D-1829-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 26, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtech Products, Inc. |
| Location | Tarrytown, NY |
| Product Type | Drugs |
| Quantity | 124,038 bottles |
Product Description
Clear Eyes Redness Relief Club Pack Display; each display contains 18 3-Pack bottles (UPC 6 78112 10552 6) of Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.12%) eye drops, 0.5 FL OZ (15 mL) bottle (individual bottle UPC 6 78112 25415 6); Distributed by Medtech Products Inc., Tarrytown, NY 10591, A Prestige Brands Company.
Reason for Recall
CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.
Distribution Pattern
Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.
Lot / Code Information
Lot #: 3-pack Q16299D2, Exp 07/19; Q162300D1, Q16260B1, Q16261B1, Q16263B1, Q16301D1, Q16302D1, Q16303D1, Q16308D1, Q16309D1, Q16336D1, Q16337D1, Q16340D1, Q16342D1, Q16343D1, Q16344D1, Exp 08/19; lot and expiry for individual products within this display are captured in each individual product Code Information
Other Recalls from Medtech Products, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1827-2019 | Class II | Clear Eyes Maximum Redness and Itchy Eye Relief... | Jul 26, 2019 |
| D-1826-2019 | Class II | Clear Eyes Assorted IRC Display; each display c... | Jul 26, 2019 |
| D-1828-2019 | Class II | Clear Eyes Assorted Sidekick Floor Stand Displa... | Jul 26, 2019 |
| D-1832-2019 | Class II | Clear Eyes Maximum Itchy Eye Relief Sidekick Fl... | Jul 26, 2019 |
| D-1833-2019 | Class II | Clear Eyes Redness Relief Handy Pocket Pal Club... | Jul 26, 2019 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.